The association between arterial stiffness and the angiotensin II type 1 receptor (A1166C) polymorphism is influenced by the use of cardiovascular medication

Journal of Hypertension

Volumn 27, Issue 1, 2009, Pages 69-75

  Plat, Arian W ^a,b   Stoffers, Henri E J H ^a   De Leeuw, Peter W ^b   Van Schayck, Constant P ^a   Soomers, Frank L ^a   Kester, Arnold D M ^c   Aretz, Karin ^a   Kroon, Abraham A ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arterial stiffness; Epidemiology; Genetics; Medication; Primary care; Pulse wave velocity; Renin angiotensin system; Single nucleotide polymorphism

Indexed keywords

ALPHA ADDUCIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN; CARDIOVASCULAR AGENT;

ADULT; AGED; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CROSS-SECTIONAL STUDY; FEMALE; FEMORAL ARTERY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PULSE WAVE; BLOOD FLOW VELOCITY; CAROTID ARTERY; GENE FREQUENCY; GENETICS; MIDDLE AGED; PHYSIOLOGY; RADIAL ARTERY;

AGED; BLOOD FLOW VELOCITY; CARDIOVASCULAR AGENTS; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RADIAL ARTERY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 58849125839     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328317f215     Document Type: Article

References (37)

1. Kitsios G, Zintzaras E. Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis. Am J Epidemiol 2007; 166:619-633.
2. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98:1123-1133.
3. Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension 2006; 48:14-20.
4. Visvikis-Siest S, Marteau JB. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 2006; 17:139-151.
5. Plat AW, te Wierik MJ, Kroon AA, Schouten HJ, van den Akker M, van Schayck CP, et al. Regional differences in cardiovascular risk factor pro?le cannot fully explain differences in cardiovascular morbidity in the Netherlands: a comparison of two urban areas. Neth JMed 2005; 63:309-315.
6. Khoshdel AR, Carney SL, Nair BR, Gillies A. Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidence-based medicine. ClinMed Res 2007;5:45-52.
7. Khoshdel AR, Thakkinstian A, Carney SL, Attia J. Estimation of an age-speci?c reference interval for pulse wave velocity: a meta-analysis. J Hypertens 2006; 24:1231-1237.
8. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
9. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
10. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117.
11. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, et al. In?uence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995; 26:44-47.
12. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. In?uence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
13. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, et al. Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001; 19:407-413.
14. Gardier S, Vincent M, Lantelme P, Rial MO, Bricca G, Milon H. A1166C polymorphism of angiotensin II type 1 receptor, blood pressure and arterial stiffness in hypertension. J Hypertens 2004; 22:2135-2142.
15. Landwehr JSTM, Akker MVD, Metsemakers JFM, Buntinx F. Comorbidity of chronic cardiovascular disorders. A cross-sectional analysis in a large general practice population in the Netherlands. Arch Public Health 2000; 58:213-231.
16. Metsemakers JF, Knottnerus JA, van Schendel GJ, Kocken RJ, Limonard CB. Unlocking patients' records in general practice for research, medical education and quality assurance: the Registration Network Family Practices. Int J Biomed Comput 1996; 42:43-50.
17. Lamberts H, Wood M, editors. ICPC: International Classi?cation of Primary Care. Oxford: Oxford University Press; 1987.
18. Classi?cation Committee of Wonca. Oxford: Oxford University Press; 1983.
19. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21:1779-1786.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
21. van der Heijden-Spek JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HA, van Bortel LM. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000; 35:637-642.
22. Cameron JD, Bulpitt CJ, Pinto ES, Rajkumar C. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care 2003; 26:2133-2138.
23. Knaapen AM, Ketelslegers HB, Gottschalk RW, Janssen RG, Paulussen AD, Smeets HJ, et al. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR ampli?cation and single base extension. Clin Chem 2004; 50:1664-1668.
24. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identi?cation of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996; 58:1268-1278.
25. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E, et al.Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998; 7:1745-1751.
26. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002; 20:2023-2027.
27. Tiret L, Bonnardeaux A, PoirierO, Ricard S,Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344:910-913.
28. Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000; 36:411-416.
29. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE eview. Am J Epidemiol 2006; 164:921-935.
30. Zeltner R, Delles C, Schneider M, Siffert W, Schmieder RE. G-protein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension 2001; 37:882-886.
31. Manunta P, Bianchi G. Low-salt diet and diuretic effect on blood pressure and organ damage. J Am Soc Nephrol 2004; 15 (Suppl 1):S43-S46.
32. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56:17-28.
33. Asmar RG, London GM, O'Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave re?ections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38:922-926.
34. Diez J, Laviades C, Orbe J, Zalba G, Lopez B, Gonzalez A, et al. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives. J Hypertens 2003; 21:2085-2092.
35. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998; 274 (1 Pt 1):C214-C220.
36. Bayraktutan U. Effects of angiotensin II on nitric oxide generation in growingand resting rat aortic endothelial cells. J Hypertens 2003; 21:2093-2101.
37. Curnow KM, Pascoe L, White PC. Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 1992; 6:1113-1118.